Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
European Journal of Surgical Oncology · 2023
DOI: 10.1016/j.ejso.2023.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023. Verfasst von Catalina A Palma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Royal Prince Alfred Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Pelvic Exenteration, Rectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: In patients with locally advanced (LARC) or locally recurrent (LRRC) rectal cancer and bladder involvement, pelvic exenteration (PE) with partial (PC) or radical (RC) cystectomy can potentially offer a cure. The study aim was to compare PC and RC in PE patients in terms of oncological outcome, post-operative complications and quality-of-life (QoL). MATERIALS & METHODS: This was a retrospective cohort analysis of a prospectively maintained surgical database. Patients who underwent PE for LARC or LRRC cancer with bladder involvement between 1998 and 2021 were included. Post-operative complications and overall survival were compared between patients with PC and RC. RESULTS: 60 PC patients and 269 RC patients were included. Overall R0 resection was 84.3%. Patients with LRRC and PC had poorest oncological outcome with 69% R0 resection; patients with LARC and PC demonstrated highest R0 rate of 96.3% (P = 0.008). Overall, 1-, 3- and 5-year OS was 90.8%, 68.1% and 58.6% after PC, and 88.7%, 62.2% and 49.5% after RC. Rates of urinary sepsis or urological leaks did not differ between groups, however, RC patients experienced significantly higher rates of perineal wound- and flap-related complications (39.8% vs 25.0%, P = 0.032). CONCLUSION: PC as part of PE can be performed safely with good oncological outcome in patients with LARC. In patients with LRRC, PC results in poor oncological outcome and a more aggressive surgical approach with RC seems justified. The main benefit of PC is a reduction in wound related complications compared to RC, although more urological re-interventions are observed in this group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Royal Prince Alfred Hospital, Sydney, Australia.
- Surgical Outcomes Research Centre (SOuRCe), Sydney, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
- Surgical Outcomes Research Centre (SOuRCe), Sydney, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery at RPA, Sydney, Australia; University of Sy…
- Institute of Academic Surgery at RPA, Sydney, Australia; University of Sydney, New South Wales, Australia; Department of Urology, Royal Prince Alfred Hospital, Sydney, Australia.
- Surgical Outcomes Research Centre (SOuRCe), Sydney, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; University of Sydney, New South Wales, Australia.
Zitieren
APA
Palma, C. A., van Kessel, C. S., Solomon, M. J., Leslie, S., Jeffery, N., Lee, P. J., & Austin, K. K. S. (2023). Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2023.01.002
Vancouver
Palma CA, van Kessel CS, Solomon MJ, Leslie S, Jeffery N, Lee PJ, et al. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?. European Journal of Surgical Oncology. 2023. doi:10.1016/j.ejso.2023.01.002
BibTeX
@article{Palma2023,
author = {Palma, Catalina A and van Kessel, Charlotte S and Solomon, Michael J and Leslie, Scott and Jeffery, Nicola and Lee, Peter J and Austin, Kirk K S},
title = {Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?},
journal = {European Journal of Surgical Oncology},
year = {2023},
doi = {10.1016/j.ejso.2023.01.002}
}
EUVIMED